3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
20
Phase 2
13
Phase 4
3
Phase 1/2
3
Phase 1
3
Status
Completed
3
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
3
Conditions
Breast Neoplasms
3
Interventions
Letrozole
5
Tamoxifen
4
Anastrozole
4
ribociclib
3
exemestane
3
atezolizumab
3
Vancomycin
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Injections
3
Human Papillomavirus Recombinant Vaccine nonavalent
3
Dexamethasone
3
Carboplatin
3
trametinib
2
relatlimab
2
pembrolizumab
2
encorafenib
2
dabrafenib
2
binimetinib
2
asciminib
2
Specimen Handling
2
Rituximab
2
Prednisone
2
Papillomavirus Vaccines
2
Oxaliplatin
2
Medroxyprogesterone Acetate
2
Leucovorin
2
Lenalidomide
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 4
×
exemestane
×
90 days
×
Clear all
NCT01127295
2026-04-14
PHACS
Institut Claudius Regaud
Phase 4
Completed
2,000 enrolled
NCT01553903
2026-04-14
OXYTAM
Institut Claudius Regaud
Phase 4
Completed
29 enrolled
NCT01612871
2026-04-14
MIRHO
Institut Claudius Regaud
Phase 4
Completed
39 enrolled